Literature DB >> 33483492

SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques.

Yashavanth Shaan Lakshmanappa1, Sonny R Elizaldi1,2, Jamin W Roh1,2, Brian A Schmidt1, Timothy D Carroll3, Kourtney D Weaver4, Justin C Smith4, Anil Verma1, Jesse D Deere3, Joseph Dutra3, Mars Stone5,6, Sergej Franz6, Rebecca Lee Sammak3, Katherine J Olstad3, J Rachel Reader3,7, Zhong-Min Ma3, Nancy K Nguyen1, Jennifer Watanabe3, Jodie Usachenko3, Ramya Immareddy3, JoAnn L Yee3, Daniela Weiskopf8, Alessandro Sette8,9, Dennis Hartigan-O'Connor3,10, Stephen J McSorley1,11, John H Morrison3,12, Nam K Tran13, Graham Simmons5,6, Michael P Busch5,6, Pamela A Kozlowski4, Koen K A Van Rompay14,15, Christopher J Miller16,17,18, Smita S Iyer19,20,21.   

Abstract

CD4 T follicular helper (Tfh) cells are important for the generation of durable and specific humoral protection against viral infections. The degree to which SARS-CoV-2 infection generates Tfh cells and stimulates the germinal center (GC) response is an important question as we investigate vaccine induced immunity against COVID-19. Here, we report that SARS-CoV-2 infection in rhesus macaques, either infused with convalescent plasma, normal plasma, or receiving no infusion, resulted in transient accumulation of pro-inflammatory monocytes and proliferating Tfh cells with a Th1 profile in peripheral blood. CD4 helper cell responses skewed predominantly toward a Th1 response in blood, lung, and lymph nodes. SARS-CoV-2 Infection induced GC Tfh cells specific for the SARS-CoV-2 spike and nucleocapsid proteins, and a corresponding early appearance of antiviral serum IgG antibodies. Collectively, the data show induction of GC responses in a rhesus model of mild COVID-19.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33483492      PMCID: PMC7822826          DOI: 10.1038/s41467-020-20642-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  45 in total

1.  Follicular dendritic cells emerge from ubiquitous perivascular precursors.

Authors:  Nike Julia Krautler; Veronika Kana; Jan Kranich; Yinghua Tian; Dushan Perera; Doreen Lemm; Petra Schwarz; Annika Armulik; Jeffrey L Browning; Michelle Tallquist; Thorsten Buch; José B Oliveira-Martins; Caihong Zhu; Mario Hermann; Ulrich Wagner; Robert Brink; Mathias Heikenwalder; Adriano Aguzzi
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

2.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

3.  Antibody responses to SARS-CoV-2 in patients with COVID-19.

Authors:  Quan-Xin Long; Bai-Zhong Liu; Hai-Jun Deng; Gui-Cheng Wu; Kun Deng; Yao-Kai Chen; Pu Liao; Jing-Fu Qiu; Yong Lin; Xue-Fei Cai; De-Qiang Wang; Yuan Hu; Ji-Hua Ren; Ni Tang; Yin-Yin Xu; Li-Hua Yu; Zhan Mo; Fang Gong; Xiao-Li Zhang; Wen-Guang Tian; Li Hu; Xian-Xiang Zhang; Jiang-Lin Xiang; Hong-Xin Du; Hua-Wen Liu; Chun-Hui Lang; Xiao-He Luo; Shao-Bo Wu; Xiao-Ping Cui; Zheng Zhou; Man-Man Zhu; Jing Wang; Cheng-Jun Xue; Xiao-Feng Li; Li Wang; Zhi-Jie Li; Kun Wang; Chang-Chun Niu; Qing-Jun Yang; Xiao-Jun Tang; Yong Zhang; Xia-Mao Liu; Jin-Jing Li; De-Chun Zhang; Fan Zhang; Ping Liu; Jun Yuan; Qin Li; Jie-Li Hu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-04-29       Impact factor: 53.440

4.  A strategic approach to COVID-19 vaccine R&D.

Authors:  Lawrence Corey; John R Mascola; Anthony S Fauci; Francis S Collins
Journal:  Science       Date:  2020-05-11       Impact factor: 47.728

5.  Seroconversion to HCoV-NL63 in Rhesus Macaques.

Authors:  Ronald Dijkman; H Lie Mulder; Lynne Rumping; Ilse Kraaijvanger; Martin Deijs; Maarten F Jebbink; Ernst J Verschoor; Lia van der Hoek
Journal:  Viruses       Date:  2009-10-30       Impact factor: 5.048

6.  CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.

Authors:  P Schaerli; K Willimann; A B Lang; M Lipp; P Loetscher; B Moser
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

7.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.

Authors:  Divij Mathew; Josephine R Giles; Amy E Baxter; Derek A Oldridge; Allison R Greenplate; Jennifer E Wu; Cécile Alanio; Leticia Kuri-Cervantes; M Betina Pampena; Kurt D'Andrea; Sasikanth Manne; Zeyu Chen; Yinghui Jane Huang; John P Reilly; Ariel R Weisman; Caroline A G Ittner; Oliva Kuthuru; Jeanette Dougherty; Kito Nzingha; Nicholas Han; Justin Kim; Ajinkya Pattekar; Eileen C Goodwin; Elizabeth M Anderson; Madison E Weirick; Sigrid Gouma; Claudia P Arevalo; Marcus J Bolton; Fang Chen; Simon F Lacey; Holly Ramage; Sara Cherry; Scott E Hensley; Sokratis A Apostolidis; Alexander C Huang; Laura A Vella; Michael R Betts; Nuala J Meyer; E John Wherry
Journal:  Science       Date:  2020-07-15       Impact factor: 47.728

Review 8.  IL-6: Relevance for immunopathology of SARS-CoV-2.

Authors:  E O Gubernatorova; E A Gorshkova; A I Polinova; M S Drutskaya
Journal:  Cytokine Growth Factor Rev       Date:  2020-05-20       Impact factor: 7.638

9.  SARS-CoV-2 surveillance for a non-human primate breeding research facility.

Authors:  JoAnn L Yee; Koen K A Van Rompay; Amanda B Carpenter; Peter B Nham; Bryson M Halley; Smita S Iyer; Dennis J Hartigan-O'Connor; Christopher J Miller; Jeffrey A Roberts
Journal:  J Med Primatol       Date:  2020-07-03       Impact factor: 0.821

10.  Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2.

Authors:  Wanbing Liu; Lei Liu; Guomei Kou; Yaqiong Zheng; Yinjuan Ding; Wenxu Ni; Qiongshu Wang; Li Tan; Wanlei Wu; Shi Tang; Zhou Xiong; Shangen Zheng
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

View more
  25 in total

1.  Proposed protocol for the investigation of the safety and efficacy of the COVID-19 vaccine for patients with psychosis, with pilot safety findings from a Chinese psychiatrist's self-experiment.

Authors:  Chongguang Lin; Tao Fang; Jiayue Chen; Qianchen Li; Weiliang Yang; Cong Yao; Lina Wang; Yun Sun; Ziyao Cai; Jing Ping; Ce Chen; Langlang Cheng; Jinjing Zhu; Guangdong Chen; Peiwei Shan; Chunmian Chen; Xiaodong Lin; Hongjun Tian; Chuanjun Zhuo
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 2.  Nonhuman Primates in Translational Research.

Authors:  Alice F Tarantal; Stephen C Noctor; Dennis J Hartigan-O'Connor
Journal:  Annu Rev Anim Biosci       Date:  2022-02-15       Impact factor: 13.341

Review 3.  Animal Models of COVID-19 II. Comparative Immunology.

Authors:  Rebecca T Veenhuis; Caroline J Zeiss
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

Review 4.  Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses.

Authors:  Matthew K Siggins; Ryan S Thwaites; Peter J M Openshaw
Journal:  Trends Microbiol       Date:  2021-04-08       Impact factor: 17.079

Review 5.  Experimental Models of COVID-19.

Authors:  Luis A Caldera-Crespo; Michael J Paidas; Sabita Roy; Carl I Schulman; Norma Sue Kenyon; Sylvia Daunert; Arumugam R Jayakumar
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

6.  Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques.

Authors:  Koen K A Van Rompay; Katherine J Olstad; Rebecca L Sammak; Joseph Dutra; Jennifer K Watanabe; Jodie L Usachenko; Ramya Immareddy; Anil Verma; Yashavanth Shaan Lakshmanappa; Brian A Schmidt; Jamin W Roh; Sonny R Elizaldi; A Mark Allen; Frauke Muecksch; Julio C C Lorenzi; Sarah Lockwood; Rachel E Pollard; JoAnn L Yee; Peter B Nham; Amir Ardeshir; Jesse D Deere; Jean Patterson; Que Dang; Theodora Hatziioannou; Paul D Bieniasz; Smita S Iyer; Dennis J Hartigan-O'Connor; Michel C Nussenzweig; J Rachel Reader
Journal:  PLoS Pathog       Date:  2021-07-06       Impact factor: 6.823

Review 7.  SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19.

Authors:  Alba Grifoni; John Sidney; Randi Vita; Bjoern Peters; Shane Crotty; Daniela Weiskopf; Alessandro Sette
Journal:  Cell Host Microbe       Date:  2021-05-21       Impact factor: 21.023

Review 8.  The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines.

Authors:  Juan Huang; Zhiyao Long; Renyong Jia; Mingshu Wang; Dekang Zhu; Mafeng Liu; Shun Chen; Xinxin Zhao; Qiao Yang; Ying Wu; Shaqiu Zhang; Bin Tian; Sai Mao; Xumin Ou; Di Sun; Qun Gao; Anchun Cheng
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

9.  Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.

Authors:  Resmi Ravindran; Cindy McReynolds; Jun Yang; Bruce D Hammock; Aamer Ikram; Amna Ali; Adnan Bashir; Tanzeel Zohra; W L William Chang; Dennis J Hartigan-O'Connor; Hooman H Rashidi; Imran H Khan
Journal:  PLoS One       Date:  2021-07-09       Impact factor: 3.240

10.  SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques.

Authors:  Carolina Garrido; Alan D Curtis; Kristina De Paris; Sallie R Permar; Maria Dennis; Sachi H Pathak; Hongmei Gao; David Montefiori; Mark Tomai; Christopher B Fox; Pamela A Kozlowski; Trevor Scobey; Jennifer E Munt; Michael L Mallory; Pooja T Saha; Michael G Hudgens; Lisa C Lindesmith; Ralph S Baric; Olubukola M Abiona; Barney Graham; Kizzmekia S Corbett; Darin Edwards; Andrea Carfi; Genevieve Fouda; Koen K A Van Rompay
Journal:  Sci Immunol       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.